M4MM
Federal Inaction on Cannabis Exports May Cost U.S. Economy $10 Billion Annually
LOS ANGELES- The United States' federal stance on cannabis exports is potentially costing the economy up to $10 billion each year, according to industry analyses. While domestic cannabis sales are projected to reach $35.3 billion ...
LEEF Brands Reports Financial Results
LOS ANGELES- LEEF Brands Inc. a vertically integrated cannabis company based in California, has released its financial results for the first quarter of 2025 and the full year of 2024. The company reported a 19% ...
California Lawmakers Advance Bill to Halt Cannabis Excise Tax Increase
LOS ANGELES- California's legal cannabis industry is confronting a potential tax increase that stakeholders warn could exacerbate existing challenges. Assembly Bill 564 (AB 564), introduced by Assemblymember Matt Haney (D-San Francisco), seeks to prevent the ...
Worried About IRS Audits? What You Need to Know
LOS ANGELES– The cannabis and psychedelics industry is undergoing a remarkable transformation, and as we one step into 2025, the outlook is brighter than ever. With increasing legalization, growing consumer acceptance, and a burgeoning market ...
Psilocybin Therapy Shows Promise for Pandemic-Induced Depression in Healthcare Workers
LOS ANGELES- Recent studies indicate that psilocybin-assisted psychotherapy may alleviate depression among healthcare professionals affected by the COVID-19 pandemic. A randomized clinical trial conducted by the University of Washington involved 30 frontline clinicians experiencing moderate to ...
Efficacy of Medical Cannabis in Treating PTSD Remains Uncertain
LOS ANGELES- The use of medical cannabis as a treatment for post-traumatic stress disorder (PTSD) has garnered significant attention. However, current research provides limited and inconclusive evidence regarding its effectiveness. A 2021 systematic review found ...
Compass Pathways Advances Psilocybin Research in the UK
LOS ANGELES- Compass Pathways, a biotechnology company specializing in mental health innovations, has commenced the UK segment of its global Phase 3 clinical trial evaluating COMP360 psilocybin therapy for treatment-resistant depression (TRD). This initiative follows ...
Federal Inaction on Cannabis Exports May Cost U.S. Economy $10 Billion Annually
LOS ANGELES- The United States' federal stance on cannabis exports is potentially costing the economy up to $10 billion each year, according to industry analyses. While domestic cannabis sales are projected to reach $35.3 billion ...
LEEF Brands Reports Financial Results
LOS ANGELES- LEEF Brands Inc. a vertically integrated cannabis company based in California, has released its financial results for the first quarter of 2025 and the full year of 2024. The company reported a 19% ...
California Lawmakers Advance Bill to Halt Cannabis Excise Tax Increase
LOS ANGELES- California's legal cannabis industry is confronting a potential tax increase that stakeholders warn could exacerbate existing challenges. Assembly Bill 564 (AB 564), introduced by Assemblymember Matt Haney (D-San Francisco), seeks to prevent the ...
